Peter on the four horsemen of chronic disease
This audio clip is from AMA #14: What lab tests can (and cannot) inform us about our overall objective of…
#301 – AMA #59: Inflammation: its impact on aging and disease risk, and how to identify, prevent, and reduce it
“Inflammation really becomes chronic once it’s persisted for several months, but it can persist for much longer than that.” —Peter Attia
Can ovarian cancer be detected by genetic analysis of cervical cancer screening samples?
A proof-of-concept method for adding ovarian cancer screening to existing protocols
Removing race as a risk factor for cardiovascular disease?
The AHA has announced a new “race-free” assessment tool, but eliminating this variable carries the potential to increase – rather than decrease – racial disparities in healthcare
#290 ‒ Liquid biopsies for early cancer detection, the role of epigenetics in aging, and the future of aging research | Alex Aravanis, M.D., Ph.D.
“Age is your single biggest risk factor for cancer. The population over 50 is about a 10x increased risk relative to the population under 50.” —Alex Aravanis
Where a study on metformin and cardiovascular disease fell short – and what it can teach us
An investigation on metformin, diabetes, lipid biology, and cardiovascular disease offered little insight on any of these topics, but it illustrates common problems in scientific research
Targeting senescent cells for cognitive health
With the recent publication of the first clinical trial of senolytics for AD treatment, popular interest in these drugs has swelled, but is the excitement justified?
The MIND diet on trial: can diet choices impact cognitive health?
The results were lackluster, but a closer look leaves room for other explanations